An Analysis of Judicial Cases Concerning Analgesic-Related Medication Errors in the Republic of Korea

Yoon, Seung Zhoo; Cho, Soo Ick; Shin, Seung Young; Lee, Wonjong; Ko, Youkang; Moon, Jee Youn; Lee, Ho-Jin

doi:10.1097/pts.0000000000000834

Cited by 2 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Considering the trends in opioid use in Korea, there is a need to evaluate opioid-related safety issues. However, there is a limitation to identifying the current status of ADEs of opioid analgesics in Korea, as studies reporting the safety of opioid analgesics use data from single-institution, judicial cases, or spontaneous ADE reports [ 18 , 19 , 20 ].…”

Section: Introductionmentioning

confidence: 99%

Risk Factors for Emergency Department Presentations after the Initiation of Opioid Analgesics in Non-Cancer Patients in Korea: A Nationwide Study

et al. 2023

View full text Add to dashboard Cite

Background and Objectives: Opioid use in Korea is lower than in other developed countries. However, recent studies have reported an increase in opioid prescriptions and the number of chronic opioid users. The current status of adverse events (AEs) associated with opioid analgesics in Korea is unclear. This nested case–control study aimed to evaluate the influence of opioid analgesic use patterns on all emergency department (ED) visits and opioid-related ED visits after opioid analgesic initiation using the national claims database. Materials and Methods: Adult non-cancer patients who initiated non-injectable opioid analgesics (NIOA) between January 2017 and June 2018 were included. We defined the case group as patients who visited the ED within six months of opioid initiation, and the control group was selected in a 1:1 ratio using an exact matching method. Results: A total of 97,735 patients (13.58%) visited the ED within six months of NIOA initiation. Nearly 32% of cases were linked to opioid-related AEs. The most frequent AEs were falls and fractures (61.27%). After adjusting for covariates, opioid initiation at the ED was associated with all-cause or opioid-related ED visits (adjusted odds ratio (aOR) = 3.19, 95% confidence interval (CI) = 3.09–3.29; aOR = 3.82, 95% CI = 3.62–4.04, respectively). Chronic NIOA use was associated with all-cause and opioid-related ED visits (aOR = 1.32, 95% CI = 1.23–1.40; aOR = 1.56, 95% CI = 1.39–1.76, respectively). Conclusion: This study found that 13% of non-cancer patients visited the ED within six months of NIOA initiation. In addition, the NIOA use pattern was significantly associated with all-cause and opioid-related ED visits.

show abstract

Section: Introductionmentioning

confidence: 99%